Skip to main content
The legacy of colonialism in treating ‘sleeping sickness’
A new drug is showing promise for an old disease — but elimination will require more than pharmaceuticals, explain ROX MIDDLETON, LIAM SHAW and JOEL HELLEWELL
Found in tropical Africa, when a tsetse fly carrying parasites bites a person, the parasitic cells enter the person’s blood. When the parasites progress to the brain they cause muscle weakness, tremors, and reversed or disturbed sleep patterns.

HUMAN African trypanosomiasis, abbreviated as HAT, is a potentially fatal disease caused by infection with a parasite, Trypanosoma brucei. The parasite is transmitted between humans via the bite of the tsetse fly. When a tsetse fly carrying parasites bites a person, the parasitic cells enter the person’s blood. There, the parasite’s cells start to divide into two and multiply.
 
This initial “blood stage” infection can cause non-specific symptoms such as fever, headaches, and joint pains. These general symptoms are difficult to diagnose as trypanosomiasis. Proper diagnosis requires looking at blood that has been treated with a special staining chemical under a microscope so that the parasite cells stand out.
 
This lack of easily noticeable symptoms has meant that many HAT cases go undetected. This is particularly concerning because, left untreated, chronic blood-stage infections will progress to the “neurological stage.” This is when the parasites cross the blood-brain barrier and infect the brain and spinal fluid.
 
When the parasites progress to the brain they cause much more severe symptoms such as muscle weakness, tremors, and confusion. Infected individuals also experience very disturbed sleeping patterns, leading to the common nickname of “sleeping sickness” for HAT cases. People’s experiences include insomnia, bouts of sudden sleepiness during the day, or a totally reversed sleeping pattern, where they are awake all night and feel sleepy all day.
 
The neurological stage also produces psychological changes in the host, producing emotional instability and psychosis. Left untreated, it will eventually lead to death. Unfortunately, once the parasites have crossed the blood-brain barrier, treatment is more difficult.

Treatment of late-stage HAT involves drug delivery over the course of 10 days in hospital, which is often not possible for people in rural locations where the disease is most likely to have gone untreated. The drugs for the neurological stage are also more toxic with greater side effects.

Though diseases like HAT and malaria had existed in tropical regions for a long time, colonialism worsened them by increasing the movement of workers between tropical regions and port cities, cramming people together. One epidemic in Uganda beginning in 1901 raged for 20 years, killing an estimated 200,000 people.

The 95th Anniversary Appeal
Support the Morning Star
You have reached the free limit.
Subscribe to continue reading.
More from this author
POISON: Centivax workers study antivenom to counteract the bites of various snakes at the company lab in San Francisco
Science and Society / 7 May 2025
7 May 2025

A maverick’s self-inflicted snake bites could unlock breakthrough treatments – but they also reveal deeper tensions between noble scientific curiosity and cold corporate callousness, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

SCIENCE AND SOCIETY / 22 April 2025
22 April 2025

Science has always been mixed up with money and power, but as a decorative facade for megayachts, it risks leaving reality behind altogether, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT

(Left) Human embryonic stem cells; (right) A patient after i
Features / 26 March 2025
26 March 2025
A small Japanese trial has reported some positive results for stem cell therapy to treat spinal-cord injuries
MORE THAN A WATERWAY: The Agua Clara (Clear Water) locks on
Science and Society / 12 March 2025
12 March 2025
Man-made canals like Panama and Suez face unprecedented challenges from extreme weather patterns and geopolitical tensions that reveal the fragility of our global trade networks, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
Similar stories
LINING THEIR POCKETS: Gilead Sciences HQ in Foster City, Cal
Science and Society / 18 December 2024
18 December 2024
Despite miraculous trial results showing new treatment could halt transmission, corporate greed and patent laws condemn millions to preventable infection and death, write ROX MIDDLETON, LIAM SHAW and MIRIAM GAUNTLETT
'Skinny jab' manufacturer Lilly has a track record of lawsui
Features / 27 October 2024
27 October 2024
Labour’s controversial plan to put the overweight and unemployed on the ‘skinny jab’ Mounjaro should set alarm bells ringing once we look into some of the research into the drug and the company set to supply it, warns CLAUDIA WEBBE